semaglutide diarrhea and vomiting Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss semaglutide vomiting law office in

The observed weight loss is generally gradual and requires regular monitoring

Published literature has explored measurable changes in body-compositionrelated biomarkers, energy balance signaling, and metabolic activity within controlled laboratory settings

Once-weekly profile ~5-day half-life from albumin-binding C20 diacid sustained exposure across the weekly research interval

You have a family medical history of blood clots or clotting disorders

3 The UK Teratology Information Service (UKTIS), which advises clinicians on medication use during pregnancy, adds that GLP-1 medication at any stage in pregnancy is not, on its own, a reason to consider ending the pregnancy or to add extra scans or tests beyond your standard antenatal care